Source: Annual Congress 2010 - Novel markers of lung injury
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Nikaido, Y. Tanino, X. Wang, S. Sato, Y. Inokoshi, N. Nakagawa, T. Ishii, A. Fukuhara, J. Saito, T. Ishida, M. Munakata (Fukushima, Japan). Role of syndecan-4 in acute lung inflammation. Eur Respir J 2010; 36: Suppl. 54, 1797

Member's Comments

No comment yet.

Related content which might interest you: Integrins αv and β3 in acute lung inflammation Source: Eur Respir J 2003; 22: Suppl. 45, 587s Year: 2003 Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation Source: Eur Respir Rev 2006; 15: 207-208 Year: 2006 The role of leptin in pulmonary neutrophilia during murine acute lung injury Source: Annual Congress 2011 - Lung cell injury and repair Year: 2011 The role of osteopontin in the pulmonary fibrosis caused by acute lung injury induced by lipopolysaccharide in rats Source: Annual Congress 2011 - Acute respiratory failure Year: 2011 P2RX4 signalling enhances acute cigarette smoke-induced lung inflammation and chronic lung emphysema development Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets Year: 2019 Effects of autophagy on LPS-induced lung inflammation and acute lung injury (ALI) in vitro and in vivo Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury Year: 2018 Ghrelin ameliorates bleomycin-induced acute lung injury by protecting alveolar epithelial cells and suppressing lung inflammation Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation Year: 2012 Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS) Year: 2006 Role of alveolar macrophages in acute lung injury model Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury Year: 2017 Mechanisms of acute lung injury Source: Lung Science Conference 2004 - Application of our knowledge of the basic processes of lung inflammation in lung diseases Year: 2004 The role of pre-receptor glucocorticoid metabolism in regulating the severity and persistence of murine lung injury Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 A role for PAR1 in lipopolysaccharide induced acute lung injury Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon Year: 2008 Enhanced expression of Robo4 ameliorates LPS-induced acute lung injury in mice Source: Annual Congress 2011 - Acute respiratory failure Year: 2011 The role of vitamin D in regulating the severity and duration of murine lung injury Source: Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights Year: 2013 Chemokine receptors in a regulation of interstitial lung fibrosis and inflammation Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Effect of protein S on lipopolysaccharide-induced acute lung injury Source: Eur Respir J 2006; 28: Suppl. 50, 398s Year: 2006 Effects of physical stress on lung mechanics, distal airway eosinophilic and lymphocytic inflammation, IL-13 expression and extracellular matrix remodeling in guinea pigs with chronic pulmonary inflammation Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009 Immunomodulatory function of chemerin and its receptor ChemR23 in the physiopathology of viral pneumonia and acute lung injury Source: Annual Congress 2011 - Lung cell injury and repair Year: 2011 Chronic intermittent hypoxia exacerbates lung fibrosis in bleomycin-induced lung injury mouse model Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities Year: 2018